Abstract
Study Design: The Minimally Invasive Versus Open Distal Pancreatectomy (LEOPARD) trial randomized 108 patients to MIDP (laparoscopic or robotic) or ODP in 14 Dutch centers (April 2015 to March 2017). The primary outcome measure of this study was quality-adjusted life years (QALYs), as assessed with the EQ-5D. QoL was assessed using subscales of the EORTC QLQ-C30, PAN-26, and a body image questionnaire. The latter included a cosmetic satisfaction score (range 3–24), and a body image score (range 5–20). Differences between MIDP and ODP for QALYs, generic, and disease-specific QoL and body image were analyzed. Missing QoL data were imputed using multiple imputation.
Results: In total, 84 patients were alive, with a median follow-up of 44 months; 62 of these patients (74%) completed the questionnaires (27 MIDP, 35 ODP). There was no significant difference in QALYs between the 2 groups (mean score 2.34 vs 2.46 years, p = 0.63), nor on the QoL subscales. Significant overall change in EQ-5D health utilities were found for both groups over time (p < 0.001). Patients in the MIDP group scored higher on cosmetic satisfaction (21 vs 14, p = 0.049). No differences between the 2 groups were observed for clinical outcomes such as major complications, readmissions, and incisional hernias.
Conclusions: More than 3 years after distal pancreatectomy, no improvement in QALYs and overall QoL was seen after MIDP, whereas cosmetic satisfaction was higher after MIDP as compared with ODP.
| Original language | English |
|---|---|
| Pages (from-to) | 730-739.e9 |
| Number of pages | 19 |
| Journal | Journal of the American College of Surgeons |
| Volume | 233 |
| Issue number | 6 |
| Early online date | 13 Oct 2021 |
| DOIs | |
| Publication status | Published - Dec 2021 |
Bibliographical note
© 2021 The Author(s).Funding
We thank all investigators of the LEOPARD trial for their contributions. The LEOPARD trial collaborators are: H. C. van Santvoort (Department of Surgery, St Antonius Hospital, Nieuwegein, and University Medical Centre Utrecht, Utrecht, the Netherlands); M. T. de Boer (Department of Surgery, University Medical Centre Groningen, Groningen, the Netherlands); D. Boerma (Department of Surgery, St Antonius Hospital, Nieuwegein, the Netherlands); P. B. van den Boezem (Department of Surgery, Radboud University Medical Centre, Nijmegen, the Netherlands); R. M. van Dam, C. H. Dejong (Department of Surgery, Maastricht University Medical Centre, Maastricht, the Netherlands, and Universitätsklinikum Aachen, Aachen, Germany); E. B. van Duyn (Department of Surgery, Medisch Spectrum Twente, Enschede, the Netherlands); C. H. van Eijck (Department of Surgery, Erasmus University Medical Centre, Rotterdam, the Netherlands); M. F. Gerhards (Department of Surgery, OLVG, Amsterdam); I. H. de Hingh (Departments of Surgery, Catharina Hospital, Eindhoven, and Netherlands Comprehensive Cancer Organisation, Utrecht, the Netherlands); G. Kazemier (Department of Surgery, Cancer Centre Amsterdam, Amsterdam UMC, VU University, Amsterdam, the Netherlands); R. H. de Kleine (Department of Surgery, University Medical Centre Groningen, Groningen, the Netherlands); C. J. van Laarhoven (Department of Surgery, Radboud University Medical Centre, Nijmegen, the Netherlands); G. A. Patijn, P. Steenvoorde (Department of Surgery, Isala Clinics, Zwolle, the Netherlands); M. Suker (Department of Surgery, Erasmus University Medical Centre, Rotterdam, the Netherlands); M. Abu Hilal (Department of General Surgery, Instituto Ospedaliero Fondazione Poliambulanza, Brescia, Italy).
| Funders |
|---|
| Maastricht University Medical Centre |
| Netherlands Comprehensive Cancer Organisation |
| Radboud University Medical Centre |
| University Medical Centre Utrecht |
| Universitätsklinikum Aachen |
| Department of Surgery |
Fingerprint
Dive into the research topics of 'Long-Term Quality of Life after Minimally Invasive vs Open Distal Pancreatectomy in the LEOPARD Randomized Trial'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver